NCT03021772View on ClinicalTrials.gov

Neostigmine Versus Dexamethasone as Adjuvants to Lidocaine During Intravenous Local Anesthesia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Adjuvants, Anesthesia
Interventions
DRUG

Neostigmine

Patients will receive intravenous 3mg/kg lidocaine 2 % (diluted with normal saline to 40 ml) + 0.5 mg neostigmine for Bier block.

DRUG

Dexamethasone

Patients will receive intravenous 3mg/kg lidocaine 2 % (diluted with normal saline to 40 ml) + 8 mg dexamethasone for Bier block.

Trial Locations (1)

71515

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03021772 - Neostigmine Versus Dexamethasone as Adjuvants to Lidocaine During Intravenous Local Anesthesia | Biotech Hunter | Biotech Hunter